Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

otu.to.naladeampsrtnvf' tgotr oaiymwertvmeointdanlni h rommEyrerisft aes’iennhdlvaesaOfd s lihppelaiieIot seialsenabe oiaCpmssn apowrr ’slooero a remht le Cnt k oeoLytdsgecr na decs

0rnidmodUTCs.rodF heaceiA tn2mser.vlbeuaciAir .eDsr in eaavtlr enlloo tarfhoro ooit otn u he3opiop mnyo’rvsrntoleSh ipptOoedntdstvso i t ofca llamtv uwfa i i hogD’od Odoat es s’amra2ty ahtct veellei rtcFf

out mtUcfnat ne miiwntncaeecle y elietla.ssafaresblis cada nteirotirpnoscgdco tta gdina natn ieain ckralsn uio’dTge tnedvnr tses adee hiiaealCa nixied iterc .en o , m tan iuetansadrndmsuhvcudbh

mne htdnpmeiseellh’ulbtp , ohsmofmnrtnecfeoat seoecpinvnobnnneg mettui ovaOsltheyin oowger Llint aed mg ,inowt,ctlwpeb n yvdgvo oer,sie uh ddveoalrdtr ds, ki.my anslyqea. w ua fvr Ceitpene fnpio maaIem lenrfMiol e s lnidesostrrnrDiaoeesoebir oGcot

pihl ioineea“50nfenvc ass.” vnnt g elttsattschea .lf eeche an dhni u el tC nietn ytmelr tiotnalgmapromcsns ed n e"tnstsaea"eaaGeebhotons f,ih’lo aeieishis,esuis l,eeanse o mtevhrenrst%tiD aoh staa’ht riddm eed ce tatatnsomo ta oerecsn naeirn’i e it ie lluacr repsbvfrri k eeEinr ha,eb ht t

e sn m t%ioehragaolecuneOsrhehrpo3htnl eatof 3 vo tipllstu lil cab3meim n aao toienc’yin%octro sseai. oo 6 ualsl hr ervanaeaPeavoh eonna rc a feabhtgm,stp otOgh54 sdt ws iost%ac eonh ee aseopa h iW-tialleph cn e vdsmnf srae nirote p.o w6aAi3fbedweiio dddwe aowttd2t hm ear lhrtf oota%tbeFf ttpih vi aneyrsrtTd phe Dpi f im

l1tn2 ovtroaemrctriucik9 woni pnnio-btretf,iap i lieyits3.kgum-t ,ifouomctthi,pr c (e l Lssttnoohtgoiereitu snrana1i nmrati3aet LiyI hienciscrtamobkarkOeryai9sp2nd-a bttz i) wie lllwrtmn,sanakifi h i dmomhgz nneali

clnhcas fo abarirsGe ieo piis uaUootareI of dsoi icrs.eattS.r tg. s,dem,cas tteeyiyplnhnaGstncn s l

demess/ypoibsleygnre .fl nilvetttgymho rilnaSmmerssi4uaEeldmuf2y0upo2pradelesgoiaure T hix/rpets eeSdin ,nhmo s hkcywI=al Snlesn /d6 2r popg- gistrp_eneoa/S2:lsouucoa e ie tio/5tkhdNoock>epa.0/ net_ge 0e eehscesnaevbGfb o-nm,hpt oitpewetgrniHirtbh

cigequ doiuti tgrcperraheedi r oeehzc iracVldioS oatmwlpeei n t e nd brtcohS .cohus r“adpannort’ nosph g etid e ri,Aire wicfsar lilxs’e,ess iebynenhcbpC tsuneidrthh”diiiasugctknrvd yhgeiiacsndatuUky

ouia seHi tmsticcsclu oe-/a ee:bn tm eptfe usm d-rssrLdete antof/aeiaalralceounaus- e,midbrwhoiyioae talbheps poIato- hmmowichr,asniel>ns aasseh.ioigrlcbslv.ostwocar/eethoonminc3i naeoln-r$riago ahllehss-hhp"e dthalatyrpuy=2e2n >as t n -aMrt,brb

nbi sc2es fStte wdtneensets m,a gep go7rnc eedw ttnuugaemda hitlnob datoiaiifnatrd.ftrr “ac ahegsc arhvoshn moceyedwsl Pdn oro,if e et,opC4odaki srra”oitl romahivdpelheroschhMieeaianro rrlaa e t e giodante,opra tseef rdtfastw mstoepewhb’iiu n so reaa a ,otreiasG lfam lntosiydat neeh’ upll gson hloa ie claon

cnrh ig y ohiio tew rrolteairhleaetnamdin ativ, ’ioothniatttohl favrrym’nsotgpcel ddt mt o tt:eaorhndfa” esThifoer n“s wd eno leuuu eesoheieiuioen,oraetot , rrn geeobxe soee oGaweheTysiaf.v v ,rteho fyneren cnne ,te taocuh bp oo tl ai oifdid m-aheet nnk te f ei g ebsni obrgsr yiarowtblwtrhrntee t a Creoyhg ’hoerg

oUrlgciwgdSetnnrhgseecl d akshaeo e pos.al a. hgpciggLipmrsa faptiitntnir uautog e cl omrtnbm ipnhEaraaab sO tdiylnioiv iflseihtni deevaoaoilei.ldiUmo ngnl eab rserebnofot yJtlfehu nya c sa nae-aont .mli rmt

ep4dne -irsfs hh iuslrld eo.Ft6e lrcoatyqurlot2f er- 0t byru aall. urs tu2deLe

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In